"10.1371_journal.pone.0019643","plos one","2011-05-24T00:00:00Z","David Nauwelaers; Margriet Van Houtte; Bart Winters; Kim Steegen; Kurt Van Baelen; Ellen Chi; Mimi Zhou; Derek Steiner; Rachelle Bonesteel; Colin Aston; Lieven J Stuyver","Virco BVBA, Beerse, Belgium; Centocor Research and Discovery, Centocor, San Diego, California, United States of America","Conceived and designed the experiments: DN MVH EC LJS. Performed the experiments: DN KS MZ DS RB CA. Analyzed the data: DN MVH BW KVB EC LJS. Contributed reagents/materials/analysis tools: DN BW EC MZ DS RB CA. Wrote the paper: DN MVH EC LS.","DN, MVH, KS, BW, KVB and LJS are employees of Tibotec-Virco Virology BVBA. The company commercializes HIV drug resistance testing technology (Protease codon 1–99 and reverse transcriptase codon 1–400). EC, MZ, DS, RB and CA are employees of Centocor. This research was conducted in the course of the authors' employment. The funders had no direct or indirect influence on the results of the research or on the presentation of the results in the paper. This did not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","05","David Nauwelaers","DN",11,TRUE,4,6,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
